What makes a peptide “nootropic”?
A nootropic is any substance claimed to improve cognitive function. A nootropic peptide is one that happens to be a peptide — a short chain of amino acids — rather than a small molecule like caffeine or a racetam.
What makes peptides interesting here is that the brain already runs on them. Neuropeptides are the body's own signaling molecules for mood, memory consolidation, stress, and appetite. Most nootropic peptides are synthetic analogues of these natural sequences, redesigned to survive longer in the body.[1]
The catch is delivery. Peptides are digested in the gut and struggle to cross the blood–brain barrier, so research compounds are usually given by nasal spray or injection rather than as pills — one reason the intranasal route dominates this field.[5] See how peptides are administered.
The main nootropic peptides
Here are the peptides most often discussed for cognition, with their honest evidence tier. None is FDA-approved in the United States for cognitive enhancement.
| Peptide | Studied for | Evidence status |
|---|---|---|
| Semax | Focus, memory, stroke recovery, neuroprotection | Registered drug in Russia; human data mostly Russian-language, limited Western replication |
| Selank | Anxiety, stress resilience, mood | Registered in Russia as an anxiolytic; small human trials, mostly single-country |
| Cerebrolysin | Stroke, traumatic brain injury, dementia | Approved in some countries; largest trial base of this group, results still debated |
| Cortexin | Cognitive impairment, brain injury recovery | Used clinically in Russia/CIS; little independent Western evidence |
| Noopept | Memory, mild cognitive impairment | A dipeptide sold as a supplement in some markets; small studies, not FDA-approved |
| P21 | Neurogenesis, memory (preclinical) | Animal research only |
| Dihexa | Synapse formation (preclinical) | Animal research only; no human data |
| Davunetide | Neuroprotection in tau disorders | Reached human trials and failed its primary endpoint — a useful cautionary case |
| Pinealon | Brain-cell protection (bioregulator) | Preclinical; see bioregulator peptides |
| DSIP | Sleep regulation | Early human and animal work; unclear, dated evidence |
Browse all of them in the cognitive & nootropic peptides category.
Semax and Selank: the two best known
These two are the peptides most people mean by "nootropic peptides," and they are frequently discussed together because both came out of the same Russian research programme and are often studied side by side.[4]
Semax
Semax is a synthetic fragment of the hormone ACTH, modified so it no longer has hormonal activity. Its most-cited mechanism is an increase in BDNF (brain-derived neurotrophic factor) and its receptor in the hippocampus — a pathway central to learning and memory in animal studies.[2] In Russia it is a registered drug used for stroke and cognitive indications.
Selank
Selank is a synthetic analogue of the immune peptide tuftsin, studied mainly as an anxiolytic rather than a stimulant. Research points to effects on GABAergic and serotonergic signaling, with animal work suggesting it reduces anxiety without the sedation or dependence associated with benzodiazepines.[3]
They are often described as complementary — Semax framed as activating, Selank as calming. That framing comes largely from user reports rather than head-to-head trials. See our detailed Semax vs. Selank comparison.
How strong is the evidence, really?
This is the part most write-ups skip. Nootropic peptides sit in an unusual evidence position: more human data than most research peptides, far less than a Western approved drug.
- Geographic concentration. The majority of clinical work on Semax, Selank, and Cortexin was conducted in Russia and neighbouring countries, often published in Russian-language journals and rarely replicated by independent Western groups.
- Small trials. Sample sizes are typically dozens of participants, not the thousands behind an approved medicine.
- Mechanism ≠ benefit. Showing a peptide raises BDNF in a rat hippocampus is a long way from showing a person thinks more clearly.[2]
- Failures happen. Davunetide looked strong preclinically and still failed its phase 3 endpoint. That outcome is the norm, not the exception.
None of this means these peptides do nothing. It means the honest summary is promising but unproven. For how to weigh claims like these yourself, see how peptide research is graded.
Peptides vs. ordinary nootropic supplements
Searches for "neuropeptide supplements" usually turn up capsules on shelves. It's worth being clear about what those are:
- Oral peptide supplements are broken down into amino acids by digestion. A peptide swallowed as a pill generally does not arrive in the bloodstream intact, which is why research compounds use nasal or injectable routes.
- Collagen peptides — the most widely sold "peptide supplement" — are a protein-derived food ingredient studied for skin and joints, not cognition. They are not nootropics.
- Nootropic peptides sold online for research use are unapproved and unregulated for purity, identity, or sterility. See are peptides legal?
Frequently asked questions
What are nootropic peptides?
Nootropic peptides are short amino-acid chains studied for effects on memory, focus, mood, and neuroprotection. The best-known are Semax, Selank, Cerebrolysin, Cortexin, and Noopept — most developed in Russia and Eastern Europe.
Which nootropic peptide has the most evidence?
Cerebrolysin has the largest clinical trial base, having been studied in stroke, traumatic brain injury, and dementia, though its results remain debated. Semax and Selank are registered drugs in Russia but have limited independent Western replication.
Do nootropic peptides actually work?
The honest answer is that they are promising but unproven. Most human trials are small, geographically concentrated, and rarely replicated independently. No nootropic peptide is FDA-approved for cognitive enhancement in the United States.
Are peptide nootropics legal?
Cerebrolysin, Semax, Selank, and Cortexin are approved prescription drugs in some countries but are not FDA-approved in the US, where they are sold only as unapproved 'research chemicals.' Legality depends entirely on your country.
Can you take nootropic peptides orally?
Generally no. Peptides are broken down by digestion, so most nootropic peptides are studied as nasal sprays or injections. Noopept is an exception — a dipeptide small enough to be studied orally.
What is the difference between Semax and Selank?
Both came from the same Russian research programme. Semax is an ACTH fragment studied for focus, memory, and stroke recovery; Selank is a tuftsin analogue studied mainly for anxiety and stress. They are often described as activating and calming respectively.
Further reading
Selected peer-reviewed sources on this topic, labelled by type. A citation is a reference, not an endorsement.
- Roesler R, Schröder N. Cognitive enhancers: focus on modulatory signaling influencing memory consolidation. Pharmacol Biochem Behav. 2011. Peer-reviewed study
- Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006. Peer-reviewed study
- Vyunova TV, Andreeva L, Shevchenko K, et al. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein Pept Lett. 2018. Peer-reviewed study
- Panikratova YR, Lebedeva IS, Sokolov OY, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020. Peer-reviewed study
- Calva CB, Fadel JR. Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction. Brain Res. 2020. Peer-reviewed study